impact factor, citescore
logo
 

Letters to the Editor

 

A case report on tocilizumab in a patient with ANCA-associated vasculitis and concurrent lung cancer


1, 2, 3, 4, 5, 6

 

  1. Department of Rheumatology and Immunology, Peking University International Hospital, Beijing, China.
  2. Peking University, Beijing, China.
  3. Department of Rheumatology and Immunology, Peking University International Hospital, Beijing, China.
  4. Department of Rheumatology and Immunology, Peking University International Hospital, Beijing, China.
  5. Department of Rheumatology and Immunology, Peking University International Hospital, Beijing, China.
  6. Department of Rheumatology and Immunology, Peking University International Hospital, Beijing, China. lishengguang@vip.sina.com

CER18446
2025 Vol.43, N°4
PI 0772, PF 0773
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 40095651 [PubMed]

Received: 16/12/2024
Accepted : 05/02/2025
In Press: 10/03/2025
Published: 08/04/2025

Rheumatology Article